If you’re looking for somewhere to invest your hard-earned money, wouldn’t you prefer it be in a sector that’s stable and can practically guarantee you secure profits?
Lucky for you, I’ve found a breakthrough that has the potential to provide you with exactly that.
The pharmaceutical sector is basically one big race to see who can get their first-of-its-kind drugs out to the public fastest.
It doesn’t matter what the products are, all you need to be concerned with is the massive pay day.
What makes these pharmaceutical companies so great is the unique research they’re doing, oftentimes things that have never been tried before.
That can spell huge profits for you—if you know which companies to look for.
These pharmaceutical companies are all part of the Health Care industry, which it’s pretty safe to say is an industry that should always be climbing.
People will always need health care, there will always be new advancements coming out, and always new research being done. Take a look at the current weekly stock chart for US Health Care (XLV).
Nothing too crazy here, but definitely a strong and steady stock.
While the Health Care industry as a whole feels like a safe bet, you still have to find the companies that are going to do more for you than just be safe.
You want the money-makers.
But what do those money-makers look like?
Well in the pharmaceuticals sector, you hope that they look something like Abeona Therapeutics (ABEO).
I’ll include their stock chart below for your eyes only, but understand that there’s a lot more to know behind the numbers.
This is a daily chart, and in it we see some very quick immediate advancement, and then a lot of continuous steady up-and-down.
However, it’s that seemingly unimpressive up-and-down that means something to us, and is going to make you a whole lot of money.
Let’s look at the weekly stock chart for ABEO and see what that tells us.
The weekly chart looks more promising, and we can also seem some patterns repeating, hopefully meaning ABEO is getting ready to shoot up.
It also allows us to see the impressive climbs ABEO stock has made, as well as putting some of those dips into perspective.
The likelihood of ABEO getting ready to shoot up becomes even greater when we look into what ABEO has been making newsworthy as of late.
When you take a look behind the curtain, you’ll see what ABEO is actually up to.
On January 29th, they managed to secure a Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for their cell therapy drug, EB-101.
Now if that sounds completely meaningless to you, I understand, and it’s nothing to worry about it.
All you need to know is that the RMAT designation means Abeona Therapeutics will be able to accelerate the process of testing, as well as be on an accelerated path to approval when their drug is ready for distribution.
Additionally, Abeona Therapeutics was presenting last week at the 14th Annual WORLDSymposium, introducing and elaborating on a lot of their current projects and researching.
